Giving patients more choice

April 15, 2004

You might be forgiven for having missed the launch of Labour's new policy statement on patient choice, Building on the …

Aventis invites Novartis ‘white knight’ bid

April 7, 2004

Aventis has formally invited Swiss rival Novartis into merger talks, but still needs to convince the French government of the …

Lilly’s ‘Le Weekender’ gaining ground on Viagra

April 7, 2004

Eli Lilly's Cialis is rapidly winning market share from Viagra, Pfizer's trailblazing erectile dysfunction (ED) drug, which is now starting …

Another April revolution to transform the NHS

April 7, 2004

For the second time in three years, the National Health Service has undergone an April revolution through the major re-engineering …

Crestor hits ‘a bump in the road’ as BMS study backfires

April 6, 2004

AstraZeneca's Crestor has suffered a setback in the US as its share in the highly competitive statin market fell back …

Medical magazines most useful form of communication, say GPs

April 6, 2004

A new survey of GPs shows they find medical publications to be the most useful of all media – results …

Contract underway but GPs gloomy about the future of health service

April 6, 2004

The long-awaited new General Medical Services contract has arrived, with the majority of general practices in the UK now working …

New ‘harmonising’ NHS watchdog begins work

April 6, 2004

'Inspecting, informing, improving' is the motto of the new watchdog for both the NHS and private healthcare facilities.

How your customers see you

April 6, 2004

When looking at the performance of new products there are many reasons for their possible success. Perhaps GPs hooked into …

Amgen pipeline boosted by $1.3bn Tularik acquisition

April 5, 2004

US biotech Amgen is to buy gene regulation specialist Tularik in a move that will add five drug candidates to …

US accused of blocking generics AIDS drug plan

April 5, 2004

Aid agencies are claiming that plans to provide antiretroviral treatment for millions of people with HIV are being undermined by …

Size isn’t everything

March 30, 2004

Pharmaceutical company sales teams have grown significantly in size over the last few years the – figures vary, but by …

New antidepressant warnings in US and Britain

March 25, 2004

New warnings about the prescribing of the Selective Serotonin Reuptake Inhibitor (SSRI) class of antidepressants have been issued in the …

The Gateway to Local Adoption Series

Latest content